Anaphylaxis is a rapid onset, life-threatening allergic reaction that requires immediate diagnosis and treatment. For patients, having access to emergency epinephrine is a necessity. Making an affordable epinephrine auto-injector device accessible to patients will ensure patients have the medicine they need, when they need it. In 2016, nearly 150,000 people signed on to a petition asking for a lower cost epinephrine auto-injector option and millions more were active in social media searching for a solution. In order to address this challenge, CVS Pharmacy partnered with Impax to purchase their epinephrine auto-injector at a price that is lower than similar brand or authorized generic epinephrine auto-injectors. These savings are passed along to the customers and patients, making the product available at the lowest cash price in the market ($109).